
Sep 24 · 3 min
A Heart Scan Startup, Peloton's Biggest Running Bet, and a $617B Longevity Market
Hale launched publicly, combining heart imaging, blood testing, and physician guidance to catch heart disease early, with 45% of their scans so far showing detectable coronary calcium · Peloton unveiled three new treadmills, including its first-ever foldable model, alongside a major push into running-specific coaching and training features · A new report maps the longevity biotech market at $617B across more than 3,000 therapeutic assets, tracking real institutional capital rather than fringe biohacker interest
Listen on Spotify